Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Adler, ID; Kliesch, U; Jentsch, I; Speicher, MR.
Induction of chromosomal aberrations by dacarbazine in somatic and germinal cells of mice.
Mutagenesis. 2002; 17(5):383-389 Doi: 10.1093/mutage/17.5.383 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-authors Med Uni Graz
Speicher Michael
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Dacarbazine (DTIC) is a chemotherapeutic agent that has been successfully applied to treat various types of cancer such as Hodgkin's disease, malignant melanomas, soft tissue sarcomas and advanced neuroblastomas. Many of the patients are of reproductive age and express concern over the genetic risk of the treatment they receive. Therefore, DTIC was tested for its clastogenic effects in somatic and germinal cells of mice. In the bone marrow micronucleus assay DTIC induced micronuclei that increased linearly in the dose range 0-125 mg/kg. In a dominant lethal study DTIC gave a positive response at the dose of 500 mg/kg when conceptions occurred 5-16 days after treatment, corresponding to treated spermatids and early spermatozoa. The induction of heritable translocations was tested in that sensitive period. The observed translocation rate among the F(1) progeny of male mice treated with 500 mg/kg DTIC was 2.13% (P < 00.1 against the historical control of 0.05%). Assuming linearity of the dose-response effect, the point estimate was used to calculate a doubling dose for the induction of heritable translocations of 12 mg/kg. Alternatively, an induced translocation rate of 41.6x10(-6) per unit dose was calculated. Both figures indicate that an increased genetic risk may exist for male patients after chemotherapy with DTIC under the assumption that germ cells of mice and humans are equally sensitive to the clastogenic effects of DTIC. However, the genetic risk is restricted to conceptions within a period of 40 days after the end of chemotherapy, since the sensitive stages of spermatogenesis are spermatids and early spermatozoa.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Antineoplastic Agents, Alkylating - toxicity
Bone Marrow - drug effects
Chromosome Aberrations - drug effects
Dacarbazine - toxicity
Dose-Response Relationship, Drug - toxicity
Female - toxicity
Fertility - drug effects
Genes, Dominant - drug effects
Genes, Lethal - drug effects
Humans - drug effects
In Situ Hybridization, Fluorescence - drug effects
Injections, Intraperitoneal - drug effects
Karyotyping - drug effects
Male - drug effects
Meiosis - genetics
Mice - genetics
Mice, Inbred C3H - genetics
Micronucleus Tests - genetics
Mitotic Index - genetics
Spermatozoa - drug effects
Translocation, Genetic - drug effects

© Med Uni GrazImprint